SIT-022

N/A

Report date: 2024/01/24 13:18:27
NME

Base Information

Drug NameSIT-022
Drug Alias NameSIT-022
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPyruvate kinase isozymes M1/M2 inhibitors
TargetsPyruvate kinase isozymes M1/M2
Therapy Area/IndicationsDermatitis, AtopicInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSitryx Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSitryx Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsDermatitis, AtopicInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A